Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. News
IDEXX Laboratories, Inc. Quantitative Score
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
IDEXX Laboratories, Inc. Earnings & Revenue
IDEXX Laboratories, Inc. Financials
Table Compare
Compare IDXX metrics with: | |||
|---|---|---|---|
Earnings & Growth | IDXX | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | IDXX | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | IDXX | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | IDXX | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
IDEXX Laboratories, Inc. Income
IDEXX Laboratories, Inc. Balance Sheet
IDEXX Laboratories, Inc. Cash Flow
IDEXX Laboratories, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Neutral |
| Return on Equity | Strong Buy |
| Return on Assets | Strong Buy |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
IDEXX Laboratories, Inc. Executives
| Name | Role |
|---|---|
| Mr. Jonathan J. Mazelsky | President, Chief Executive Officer & Director |
| Mr. Brian P. McKeon | Chief Financial Officer, Executive Vice President & Treasurer |
| Mr. Michael J. Lane | Executive Vice President and GM of Reference Laboratories & Information Technology |
| Ms. Sharon E. Underberg | Executive Vice President, General Counsel, & Corporate Secretary |
| Mr. Jeffery D. Chadbourne | Senior Vice President of Commercial Finance & Sales Operations |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Jonathan J. Mazelsky | President, Chief Executive Officer & Director | Male | 1961 | 2.77M |
| Mr. Brian P. McKeon | Chief Financial Officer, Executive Vice President & Treasurer | Male | 1962 | 1.4M |
| Mr. Michael J. Lane | Executive Vice President and GM of Reference Laboratories & Information Technology | Male | 1969 | 1.17M |
| Ms. Sharon E. Underberg | Executive Vice President, General Counsel, & Corporate Secretary | Female | 1961 | 881.05K |
| Mr. Jeffery D. Chadbourne | Senior Vice President of Commercial Finance & Sales Operations | Male | 1976 | -- |
IDEXX Laboratories, Inc. Insider Trades
| Date | 17 May |
| Name | Claflin Bruce L. |
| Role | Director |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 200 |
| Date | 6 May |
| Name | Vandebroek Sophie V. |
| Role | Director |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 257 |
| Date | 6 May |
| Name | Vandebroek Sophie V. |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 609 |
| Date | 6 May |
| Name | Vandebroek Sophie V. |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 262 |
| Date | 6 May |
| Name | Vandebroek Sophie V. |
| Role | Director |
| Transaction | Disposed |
| Type | M-Exempt |
| Shares | 257 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 17 May | Claflin Bruce L. | Director | Disposed | S-Sale | 200 |
| 6 May | Vandebroek Sophie V. | Director | Acquired | M-Exempt | 257 |
| 6 May | Vandebroek Sophie V. | Director | Acquired | A-Award | 609 |
| 6 May | Vandebroek Sophie V. | Director | Acquired | A-Award | 262 |
| 6 May | Vandebroek Sophie V. | Director | Disposed | M-Exempt | 257 |